Drug utilization patterns and healthcare resource use and costs in patients with neurogenic bladder in the United Kingdom: A retrospective primary care database study

被引:6
作者
Jaggi, Ashley [1 ,2 ]
Nazir, Jameel [2 ]
Fatoye, Francis [1 ]
Siddiqui, Emad [2 ]
Choudhury, Nurul [2 ]
Argoubi, Ramzi [3 ]
Ali, Mahmood [1 ,2 ]
de Ridder, Dirk [4 ]
Drake, Marcus J. [5 ]
机构
[1] Manchester Metropolitan Univ, Dept Hlth Profess, Manchester, Lancs, England
[2] Astellas Pharma Europe Ltd, Hlth Econ & Outcomes Res, Chertsey, England
[3] Creativ Ceut SARL, Hlth Econ & Outcomes Res, Les Berges Du Lac, Tunisia
[4] Univ Leuven, Dept Urol Organ Syst Dev & Regenerat, Leuven, Belgium
[5] Univ Bristol, Sch Clin Sci, Bristol Med Sch, Translat Hlth Sci, Bristol, Avon, England
基金
“创新英国”项目;
关键词
cholinergic antagonists; comorbidity; healthcare costs; healthcare resources; neurogenic; retrospective studies; urinary bladder; MANAGEMENT; EPIDEMIOLOGY;
D O I
10.1002/nau.23981
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim To characterize patients with neurogenic bladder (NGB), their treatment patterns, healthcare resource utilization, and associated costs based on records from a primary care database in the United Kingdom. Methods This was a retrospective, descriptive, observational study of anonymized data from the Clinical Practice Research Datalink and Hospital Episode Statistics databases (selection period, 1 January 2004 to 31 December 2016). Adults with a definitive or probable diagnosis of NGB and >= 1 referral to a urologist were included. Results The study cohort included 3913 patients with definitive (n = 363) or probable (n = 3550) NGB. Patients had a mean of 8.6 (standard deviation [SD], 7.6) comorbidities, and mean Anticholinergic Cognitive Burden Scale score of 6.6 (SD, 5.9). During 12 months' follow-up, urinary tract infection (UTI) and urinary incontinence were the most common complications. Most patients (92.2%) received >= 1 prescription for an antimuscarinic agent or mirabegron, and 53.9% of patients received prescriptions for UTI-specific antibiotics. The mean number of visits to a general practitioner for any cause was 67.7 (SD, 42.6) per individual. Almost half (46.7%) of the study cohort visited a specialist during the 12-month follow-up period, and 11.0% had >= 1 hospital admission. Total mean per patient costs for healthcare resource utilization was 2395 pound. Conclusions The burden of illness, healthcare resource needs, and associated costs among patients with NGB are considerable. Drug prescribing patterns are consistent with the symptoms and complications of NGB, although increased awareness of drugs with anticholinergic activity among prescribers may help to reduce the cumulative anticholinergic burden in this vulnerable population.
引用
收藏
页码:1278 / 1289
页数:12
相关论文
共 50 条
  • [31] Resource use and costs associated with patients treated for depression in primary care
    Sobocki, P.
    Ekman, M.
    Agren, H.
    Krakau, I.
    Runeson, B.
    Martensson, B.
    Jonsson, B.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2007, 8 (01) : 67 - 76
  • [32] Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study
    Bergman, Martin
    Zhou, Lili
    Patel, Pankaj
    Sawant, Ruta
    Clewell, Jerry
    Tundia, Namita
    ADVANCES IN THERAPY, 2021, 38 (05) : 2558 - 2570
  • [33] Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service Medicare beneficiaries with schizophrenia in the United States
    Li, Pengxiang
    Benson, Carmela
    Geng, Zhi
    Seo, Sanghyuk
    Patel, Charmi
    Doshi, Jalpa A. A.
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 525 - 536
  • [34] Characteristics, treatment patterns, healthcare resource use, and costs among pediatric patients diagnosed with neurofibromatosis type 1 and plexiform neurofibromas: a retrospective database analysis of a medicaid population
    Yang, Xiaoqin
    Desai, Kaushal
    Agrawal, Neha
    Mirchandani, Kirti
    Chatterjee, Sagnik
    Sarpong, Eric
    Sen, Shuvayu
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1555 - 1561
  • [35] Hospital Healthcare Resource Utilization and Associated Hospital Costs of Patients With Lupus Nephritis in China: A National Administrative Claim Database Study
    He, Xin
    Zhu, Xiaochen
    Tang, Zhiliu
    Gairy, Kerry
    Juliao, Patricia
    Wu, Zongxi
    Han, Sheng
    VALUE IN HEALTH REGIONAL ISSUES, 2024, 43
  • [36] Primary Care Behavioral Health Integration and Care Utilization: Implications for Patient Outcome and Healthcare Resource Use
    Maeng, Daniel D.
    Poleshuck, Ellen
    Rosenberg, Tziporah
    Kulak, Amie
    Mahoney, Thomas
    Nasra, George
    Lee, Hochang B.
    Li, Yue
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (11) : 2691 - 2697
  • [37] Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis
    Gauthier, Genevieve
    Guerin, Annie
    Zhdanava, Maryia
    Jacobson, William
    Nomikos, George
    Merikle, Elizabeth
    Francois, Clement
    Perez, Vanessa
    BMC PSYCHIATRY, 2017, 17
  • [38] Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis
    Geneviève Gauthier
    Annie Guérin
    Maryia Zhdanava
    William Jacobson
    George Nomikos
    Elizabeth Merikle
    Clément François
    Vanessa Perez
    BMC Psychiatry, 17
  • [39] Hypereosinophilic syndrome in Europe: Retrospective study of treatment patterns, clinical manifestations, and healthcare resource utilization
    Hwee, Jeremiah
    Huynh, Lynn
    Du, Shawn
    Kwon, Namhee
    Jakes, Rupert W.
    Alfonso-Cristancho, Rafael
    Baylis, Lee
    Requena, Gema
    Khanal, Anamika
    Rothenberg, Marc E.
    Duh, Mei Sheng
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (06) : 768 - 775
  • [40] Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study
    Hudesman, David P.
    Chakravarty, Soumya D.
    Emond, Bruno
    Ellis, Lorie A.
    Lefebvre, Patrick
    Sadik, Kay
    Scher, Jose U.
    BMC RHEUMATOLOGY, 2020, 4 (01)